
A Cost-Effectiveness Comparison of Alosetron, Eluxadoline, and Rifaximin in the Treatment of Irritable Bowel Syndrome with Diarrhea
Author(s) -
Sujit S. Sansgiry
Publication year - 2016
Publication title -
pharmacy and pharmacology international journal
Language(s) - English
Resource type - Journals
ISSN - 2379-6367
DOI - 10.15406/ppij.2016.04.00095
Subject(s) - irritable bowel syndrome , rifaximin , medicine , diarrhea , gastroenterology , antibiotics , microbiology and biotechnology , biology